nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—IMPA2—bipolar disorder	0.281	0.329	CbGaD
Lithium—GSK3A—bipolar disorder	0.213	0.249	CbGaD
Lithium—IMPA1—bipolar disorder	0.213	0.249	CbGaD
Lithium—GSK3B—bipolar disorder	0.148	0.173	CbGaD
Lithium—GRIA3—adrenal cortex—bipolar disorder	0.00381	0.108	CbGeAlD
Lithium—GSK3A—adrenal cortex—bipolar disorder	0.00287	0.0813	CbGeAlD
Lithium—IMPA1—nervous system—bipolar disorder	0.00262	0.0744	CbGeAlD
Lithium—IMPA2—thyroid gland—bipolar disorder	0.00234	0.0664	CbGeAlD
Lithium—GSK3B—thyroid gland—bipolar disorder	0.0023	0.0652	CbGeAlD
Lithium—GRIA3—nervous system—bipolar disorder	0.00223	0.0633	CbGeAlD
Lithium—GRIA3—cerebellum—bipolar disorder	0.0021	0.0596	CbGeAlD
Lithium—IMPA1—brain—bipolar disorder	0.00201	0.0569	CbGeAlD
Lithium—GSK3A—thyroid gland—bipolar disorder	0.002	0.0567	CbGeAlD
Lithium—GSK3B—nervous system—bipolar disorder	0.00193	0.0548	CbGeAlD
Lithium—GSK3B—cerebellum—bipolar disorder	0.00182	0.0516	CbGeAlD
Lithium—GRIA3—brain—bipolar disorder	0.00171	0.0484	CbGeAlD
Lithium—GSK3A—nervous system—bipolar disorder	0.00168	0.0477	CbGeAlD
Lithium—GSK3A—cerebellum—bipolar disorder	0.00158	0.0448	CbGeAlD
Lithium—IMPA2—brain—bipolar disorder	0.0015	0.0427	CbGeAlD
Lithium—GSK3B—brain—bipolar disorder	0.00148	0.0419	CbGeAlD
Lithium—GSK3A—brain—bipolar disorder	0.00128	0.0364	CbGeAlD
Lithium—GRIA3—Neuronal System—COMT—bipolar disorder	0.000135	0.00122	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—NRG1—bipolar disorder	0.000135	0.00122	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—NRG1—bipolar disorder	0.000134	0.00121	CbGpPWpGaD
Lithium—GRIA3—Neuronal System—MAOA—bipolar disorder	0.000134	0.00121	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—HLA-E—bipolar disorder	0.000133	0.00121	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—NRG1—bipolar disorder	0.000133	0.00121	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—NRG1—bipolar disorder	0.000133	0.0012	CbGpPWpGaD
Lithium—GSK3A—Leptin signaling pathway—IL1B—bipolar disorder	0.000133	0.0012	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling events of B Cell Receptor (BCR)—NRG1—bipolar disorder	0.000131	0.00118	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—GSK3A—bipolar disorder	0.000131	0.00118	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—GSK3A—bipolar disorder	0.000131	0.00118	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—GSK3A—bipolar disorder	0.000131	0.00118	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—GSK3A—bipolar disorder	0.00013	0.00117	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—ADCY2—bipolar disorder	0.000129	0.00117	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—NTRK1—bipolar disorder	0.000129	0.00117	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—ADCY2—bipolar disorder	0.000129	0.00117	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—GSK3A—bipolar disorder	0.000128	0.00116	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—ADCY2—bipolar disorder	0.000128	0.00116	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—GSK3A—bipolar disorder	0.000128	0.00116	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—ADCY2—bipolar disorder	0.000127	0.00115	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—NTRK1—bipolar disorder	0.000127	0.00115	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—HLA-E—bipolar disorder	0.000125	0.00113	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—BDNF—bipolar disorder	0.000125	0.00113	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—NRG1—bipolar disorder	0.000125	0.00113	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—NRG1—bipolar disorder	0.000125	0.00113	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—NRG1—bipolar disorder	0.000125	0.00113	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—NRG1—bipolar disorder	0.000124	0.00112	CbGpPWpGaD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—POMC—bipolar disorder	0.000123	0.00111	CbGpPWpGaD
Lithium—IMPA2—Metabolism—CLOCK—bipolar disorder	0.000123	0.00111	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—NRG1—bipolar disorder	0.000123	0.00111	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—SLC6A4—bipolar disorder	0.000122	0.00111	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—DRD1—bipolar disorder	0.000122	0.00111	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—NRG1—bipolar disorder	0.000122	0.0011	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—NTRK2—bipolar disorder	0.000122	0.0011	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—GSK3A—bipolar disorder	0.000121	0.00109	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—ADCY2—bipolar disorder	0.00012	0.00109	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—ADCY2—bipolar disorder	0.00012	0.00109	CbGpPWpGaD
Lithium—IMPA2—Metabolism—TSHB—bipolar disorder	0.00012	0.00108	CbGpPWpGaD
Lithium—IMPA2—Metabolism—TPH2—bipolar disorder	0.00012	0.00108	CbGpPWpGaD
Lithium—IMPA2—Metabolism—CACNB2—bipolar disorder	0.00012	0.00108	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—ADCY2—bipolar disorder	0.000119	0.00108	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—DRD3—bipolar disorder	0.000119	0.00107	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—S100B—bipolar disorder	0.000118	0.00107	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—ADCY2—bipolar disorder	0.000118	0.00107	CbGpPWpGaD
Lithium—IMPA2—Metabolism—DPYD—bipolar disorder	0.000118	0.00107	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—ADCY2—bipolar disorder	0.000117	0.00106	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—NTRK2—bipolar disorder	0.000117	0.00106	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—BDNF—bipolar disorder	0.000116	0.00105	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—GSK3A—bipolar disorder	0.000116	0.00105	CbGpPWpGaD
Lithium—GSK3A—B Cell Activation—NRG1—bipolar disorder	0.000115	0.00105	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—DRD4—bipolar disorder	0.000115	0.00104	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—GRIN1—bipolar disorder	0.000115	0.00104	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—MB21D1—bipolar disorder	0.000115	0.00104	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—TRPC3—bipolar disorder	0.000112	0.00102	CbGpPWpGaD
Lithium—GSK3B—Corticotropin-releasing hormone—POMC—bipolar disorder	0.000112	0.00101	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—NRG1—bipolar disorder	0.000111	0.001	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—ADCY2—bipolar disorder	0.000111	0.001	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—NRG1—bipolar disorder	0.000111	0.001	CbGpPWpGaD
Lithium—IMPA1—Metabolism—CLOCK—bipolar disorder	0.000109	0.00099	CbGpPWpGaD
Lithium—IMPA2—Metabolism—CACNA1C—bipolar disorder	0.000109	0.00099	CbGpPWpGaD
Lithium—GSK3A—Signaling by SCF-KIT—GSK3B—bipolar disorder	0.000109	0.000983	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—NCAN—bipolar disorder	0.000108	0.000978	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—DRD2—bipolar disorder	0.000107	0.00097	CbGpPWpGaD
Lithium—IMPA1—Metabolism—TPH2—bipolar disorder	0.000107	0.000965	CbGpPWpGaD
Lithium—IMPA1—Metabolism—TSHB—bipolar disorder	0.000107	0.000965	CbGpPWpGaD
Lithium—IMPA2—Metabolism—PIK3C2A—bipolar disorder	0.000107	0.000965	CbGpPWpGaD
Lithium—IMPA1—Metabolism—CACNB2—bipolar disorder	0.000107	0.000965	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—ADCY2—bipolar disorder	0.000106	0.000962	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—ANK3—bipolar disorder	0.000106	0.000958	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—NRG1—bipolar disorder	0.000106	0.000958	CbGpPWpGaD
Lithium—IMPA1—Metabolism—DPYD—bipolar disorder	0.000105	0.00095	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—CACNB2—bipolar disorder	0.000105	0.000946	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—NRG1—bipolar disorder	0.000104	0.000943	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling of activated FGFR—GSK3B—bipolar disorder	0.000104	0.000941	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—GSK3B—bipolar disorder	0.000102	0.000926	CbGpPWpGaD
Lithium—GSK3B—TCF dependent signaling in response to WNT—TCF7L2—bipolar disorder	0.000101	0.000916	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—INS—bipolar disorder	0.0001	0.000908	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—NRG1—bipolar disorder	9.95e-05	0.0009	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—NTRK1—bipolar disorder	9.91e-05	0.000897	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—NRG1—bipolar disorder	9.9e-05	0.000896	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—NRG1—bipolar disorder	9.85e-05	0.000891	CbGpPWpGaD
Lithium—GSK3A—Insulin Signaling—GSK3B—bipolar disorder	9.82e-05	0.000889	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—NRG1—bipolar disorder	9.8e-05	0.000887	CbGpPWpGaD
Lithium—GSK3B—RNF mutants show enhanced WNT signaling and proliferation—TCF7L2—bipolar disorder	9.79e-05	0.000887	CbGpPWpGaD
Lithium—GSK3B—Leptin signaling pathway—IL1B—bipolar disorder	9.79e-05	0.000886	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—GSK3B—bipolar disorder	9.77e-05	0.000884	CbGpPWpGaD
Lithium—IMPA1—Metabolism—CACNA1C—bipolar disorder	9.75e-05	0.000883	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—GSK3B—bipolar disorder	9.72e-05	0.00088	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—NTRK1—bipolar disorder	9.71e-05	0.000879	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—GSK3B—bipolar disorder	9.68e-05	0.000876	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—NRG1—bipolar disorder	9.66e-05	0.000874	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—GSK3B—bipolar disorder	9.63e-05	0.000871	CbGpPWpGaD
Lithium—IMPA2—Metabolism—SNAP25—bipolar disorder	9.56e-05	0.000866	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—CACNA1C—bipolar disorder	9.56e-05	0.000865	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—NTRK1—bipolar disorder	9.52e-05	0.000862	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PIK3C2A—bipolar disorder	9.5e-05	0.00086	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling events of B Cell Receptor (BCR)—GSK3B—bipolar disorder	9.49e-05	0.000859	CbGpPWpGaD
Lithium—GSK3B—Alzheimers Disease—IL1B—bipolar disorder	9.39e-05	0.00085	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—NRG1—bipolar disorder	9.22e-05	0.000835	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—NRG1—bipolar disorder	9.22e-05	0.000835	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—NRG1—bipolar disorder	9.22e-05	0.000835	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—NRG1—bipolar disorder	9.14e-05	0.000827	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—TCF7L2—bipolar disorder	9.1e-05	0.000823	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—GSK3B—bipolar disorder	9.06e-05	0.00082	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—GSK3B—bipolar disorder	9.06e-05	0.00082	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—GSK3B—bipolar disorder	9.06e-05	0.00082	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—NRG1—bipolar disorder	9.06e-05	0.00082	CbGpPWpGaD
Lithium—GSK3A—Immune System—MB21D1—bipolar disorder	9.04e-05	0.000818	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—NRG1—bipolar disorder	9.02e-05	0.000816	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—NTRK2—bipolar disorder	8.98e-05	0.000813	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—GSK3B—bipolar disorder	8.98e-05	0.000813	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—GSK3A—bipolar disorder	8.9e-05	0.000806	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—GSK3B—bipolar disorder	8.9e-05	0.000805	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—GSK3B—bipolar disorder	8.86e-05	0.000802	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—NRG1—bipolar disorder	8.53e-05	0.000772	CbGpPWpGaD
Lithium—IMPA1—Metabolism—SNAP25—bipolar disorder	8.52e-05	0.000772	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—NRG1—bipolar disorder	8.5e-05	0.000769	CbGpPWpGaD
Lithium—IMPA2—Metabolism—ADCY2—bipolar disorder	8.46e-05	0.000766	CbGpPWpGaD
Lithium—GSK3A—B Cell Activation—GSK3B—bipolar disorder	8.38e-05	0.000759	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—GRIN1—bipolar disorder	8.19e-05	0.000741	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—ADCY2—bipolar disorder	8.17e-05	0.00074	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—NRG1—bipolar disorder	8.17e-05	0.000739	CbGpPWpGaD
Lithium—GSK3A—Disease—AKR1C4—bipolar disorder	8.08e-05	0.000732	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—GSK3B—bipolar disorder	8.02e-05	0.000726	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TRPC3—bipolar disorder	8.02e-05	0.000726	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—TSHB—bipolar disorder	7.79e-05	0.000705	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—GRIN2B—bipolar disorder	7.56e-05	0.000684	CbGpPWpGaD
Lithium—IMPA1—Metabolism—ADCY2—bipolar disorder	7.54e-05	0.000683	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—TCF7L2—bipolar disorder	7.5e-05	0.000679	CbGpPWpGaD
Lithium—GSK3B—Senescence and Autophagy in Cancer—IL1B—bipolar disorder	7.48e-05	0.000677	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—CACNB2—bipolar disorder	7.46e-05	0.000675	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—NTRK1—bipolar disorder	7.32e-05	0.000663	CbGpPWpGaD
Lithium—IMPA2—Metabolism—COMT—bipolar disorder	7.25e-05	0.000656	CbGpPWpGaD
Lithium—IMPA2—Metabolism—MAOA—bipolar disorder	7.2e-05	0.000651	CbGpPWpGaD
Lithium—GSK3A—Disease—NCAN—bipolar disorder	6.94e-05	0.000629	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—CACNA1C—bipolar disorder	6.82e-05	0.000617	CbGpPWpGaD
Lithium—GSK3A—Disease—SLC5A3—bipolar disorder	6.8e-05	0.000616	CbGpPWpGaD
Lithium—GSK3B—Immune System—MB21D1—bipolar disorder	6.68e-05	0.000605	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—HLA-E—bipolar disorder	6.59e-05	0.000597	CbGpPWpGaD
Lithium—IMPA1—Metabolism—COMT—bipolar disorder	6.46e-05	0.000585	CbGpPWpGaD
Lithium—IMPA1—Metabolism—MAOA—bipolar disorder	6.41e-05	0.000581	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—HLA-E—bipolar disorder	6.33e-05	0.000573	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—ADCY2—bipolar disorder	6.31e-05	0.000571	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—NRG1—bipolar disorder	6.28e-05	0.000569	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—GSK3B—bipolar disorder	6.17e-05	0.000559	CbGpPWpGaD
Lithium—GSK3B—Disease—AKR1C4—bipolar disorder	5.97e-05	0.000541	CbGpPWpGaD
Lithium—IMPA2—Metabolism—MTHFR—bipolar disorder	5.86e-05	0.00053	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AKR1C4—bipolar disorder	5.66e-05	0.000512	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—S100B—bipolar disorder	5.49e-05	0.000497	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—TCF7L2—bipolar disorder	5.49e-05	0.000497	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—GRIN2B—bipolar disorder	5.39e-05	0.000488	CbGpPWpGaD
Lithium—IMPA1—Metabolism—MTHFR—bipolar disorder	5.22e-05	0.000473	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—DGKH—bipolar disorder	5.21e-05	0.000471	CbGpPWpGaD
Lithium—GSK3B—Disease—NCAN—bipolar disorder	5.13e-05	0.000464	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—GSK3A—bipolar disorder	5.08e-05	0.00046	CbGpPWpGaD
Lithium—GSK3B—Disease—SLC5A3—bipolar disorder	5.03e-05	0.000455	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—GSK3A—bipolar disorder	4.88e-05	0.000441	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—HLA-E—bipolar disorder	4.87e-05	0.000441	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—NRG1—bipolar disorder	4.85e-05	0.000439	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—DRD5—bipolar disorder	4.76e-05	0.000431	CbGpPWpGaD
Lithium—IMPA2—Metabolism—POMC—bipolar disorder	4.69e-05	0.000424	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HLA-E—bipolar disorder	4.68e-05	0.000423	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RGS4—bipolar disorder	4.67e-05	0.000423	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—ADCY2—bipolar disorder	4.66e-05	0.000422	CbGpPWpGaD
Lithium—IMPA2—Metabolism—INS—bipolar disorder	4.66e-05	0.000422	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—NRG1—bipolar disorder	4.66e-05	0.000421	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AKR1C4—bipolar disorder	4.18e-05	0.000379	CbGpPWpGaD
Lithium—IMPA1—Metabolism—POMC—bipolar disorder	4.18e-05	0.000378	CbGpPWpGaD
Lithium—IMPA1—Metabolism—INS—bipolar disorder	4.15e-05	0.000376	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—S100B—bipolar disorder	4.06e-05	0.000367	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DGKH—bipolar disorder	3.85e-05	0.000348	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-E—bipolar disorder	3.84e-05	0.000348	CbGpPWpGaD
Lithium—GSK3A—Disease—SNAP25—bipolar disorder	3.83e-05	0.000347	CbGpPWpGaD
Lithium—GSK3A—Immune System—ADCY2—bipolar disorder	3.67e-05	0.000332	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TRPC3—bipolar disorder	3.61e-05	0.000327	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—NRG1—bipolar disorder	3.58e-05	0.000324	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DRD5—bipolar disorder	3.52e-05	0.000319	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—GSK3B—bipolar disorder	3.52e-05	0.000319	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RGS4—bipolar disorder	3.45e-05	0.000312	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ADM—bipolar disorder	3.44e-05	0.000312	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—NRG1—bipolar disorder	3.44e-05	0.000311	CbGpPWpGaD
Lithium—GSK3A—Disease—ADCY2—bipolar disorder	3.39e-05	0.000307	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—GSK3B—bipolar disorder	3.38e-05	0.000306	CbGpPWpGaD
Lithium—GSK3A—Disease—TCF7L2—bipolar disorder	3.38e-05	0.000306	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TSHB—bipolar disorder	3.36e-05	0.000304	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PDE4B—bipolar disorder	3.36e-05	0.000304	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TACR1—bipolar disorder	3.36e-05	0.000304	CbGpPWpGaD
Lithium—GSK3A—Immune System—S100B—bipolar disorder	3.2e-05	0.00029	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—POMC—bipolar disorder	3.05e-05	0.000276	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—INS—bipolar disorder	3.03e-05	0.000275	CbGpPWpGaD
Lithium—GSK3B—Immune System—GSK3A—bipolar disorder	2.96e-05	0.000268	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—INS—bipolar disorder	2.9e-05	0.000263	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-E—bipolar disorder	2.84e-05	0.000257	CbGpPWpGaD
Lithium—GSK3B—Disease—SNAP25—bipolar disorder	2.83e-05	0.000256	CbGpPWpGaD
Lithium—GSK3A—Immune System—NRG1—bipolar disorder	2.82e-05	0.000256	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR1A—bipolar disorder	2.78e-05	0.000251	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TAC1—bipolar disorder	2.74e-05	0.000248	CbGpPWpGaD
Lithium—GSK3B—Disease—GSK3A—bipolar disorder	2.73e-05	0.000247	CbGpPWpGaD
Lithium—GSK3B—Immune System—ADCY2—bipolar disorder	2.71e-05	0.000246	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—DRD1—bipolar disorder	2.68e-05	0.000243	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR2C—bipolar disorder	2.68e-05	0.000243	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TRPC3—bipolar disorder	2.67e-05	0.000241	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NTRK2—bipolar disorder	2.61e-05	0.000236	CbGpPWpGaD
Lithium—GSK3A—Disease—NRG1—bipolar disorder	2.61e-05	0.000236	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—DRD3—bipolar disorder	2.6e-05	0.000235	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADM—bipolar disorder	2.55e-05	0.00023	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—DRD4—bipolar disorder	2.52e-05	0.000228	CbGpPWpGaD
Lithium—GSK3B—Disease—ADCY2—bipolar disorder	2.51e-05	0.000227	CbGpPWpGaD
Lithium—GSK3B—Disease—TCF7L2—bipolar disorder	2.5e-05	0.000226	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TSHB—bipolar disorder	2.48e-05	0.000225	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PDE4B—bipolar disorder	2.48e-05	0.000225	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TACR1—bipolar disorder	2.48e-05	0.000225	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ADCY2—bipolar disorder	2.37e-05	0.000215	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TCF7L2—bipolar disorder	2.37e-05	0.000214	CbGpPWpGaD
Lithium—GSK3B—Immune System—S100B—bipolar disorder	2.36e-05	0.000214	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—DRD2—bipolar disorder	2.35e-05	0.000213	CbGpPWpGaD
Lithium—GSK3A—Disease—MTHFR—bipolar disorder	2.35e-05	0.000212	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NTRK1—bipolar disorder	2.13e-05	0.000193	CbGpPWpGaD
Lithium—GSK3B—Immune System—NRG1—bipolar disorder	2.09e-05	0.000189	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—S100B—bipolar disorder	2.07e-05	0.000187	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR1A—bipolar disorder	2.05e-05	0.000186	CbGpPWpGaD
Lithium—GSK3A—Immune System—GSK3B—bipolar disorder	2.05e-05	0.000186	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TAC1—bipolar disorder	2.02e-05	0.000183	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DRD1—bipolar disorder	1.98e-05	0.000179	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR2C—bipolar disorder	1.98e-05	0.000179	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NTRK2—bipolar disorder	1.93e-05	0.000175	CbGpPWpGaD
Lithium—GSK3B—Disease—NRG1—bipolar disorder	1.93e-05	0.000174	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DRD3—bipolar disorder	1.92e-05	0.000174	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GSK3A—bipolar disorder	1.91e-05	0.000173	CbGpPWpGaD
Lithium—GSK3A—Disease—GSK3B—bipolar disorder	1.89e-05	0.000171	CbGpPWpGaD
Lithium—GSK3A—Disease—INS—bipolar disorder	1.87e-05	0.000169	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DRD4—bipolar disorder	1.86e-05	0.000169	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NRG1—bipolar disorder	1.83e-05	0.000165	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADCY2—bipolar disorder	1.75e-05	0.000159	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TCF7L2—bipolar disorder	1.75e-05	0.000158	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DRD2—bipolar disorder	1.74e-05	0.000157	CbGpPWpGaD
Lithium—GSK3B—Disease—MTHFR—bipolar disorder	1.73e-05	0.000157	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR2A—bipolar disorder	1.65e-05	0.000149	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NTRK1—bipolar disorder	1.57e-05	0.000142	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—S100B—bipolar disorder	1.53e-05	0.000138	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL1B—bipolar disorder	1.51e-05	0.000137	CbGpPWpGaD
Lithium—GSK3B—Disease—INS—bipolar disorder	1.38e-05	0.000125	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NRG1—bipolar disorder	1.35e-05	0.000122	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GSK3B—bipolar disorder	1.33e-05	0.00012	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—POMC—bipolar disorder	1.31e-05	0.000119	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—INS—bipolar disorder	1.31e-05	0.000118	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR2A—bipolar disorder	1.22e-05	0.00011	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL1B—bipolar disorder	1.11e-05	0.000101	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—POMC—bipolar disorder	9.71e-06	8.79e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—INS—bipolar disorder	9.66e-06	8.74e-05	CbGpPWpGaD
